Taiwan Genome Industry Alliance
Taiwan Genome Industry Alliance Inc. (TGI) is a disease-focused company driven by genomics sequencing and data. They are the sole technology transfer and licensing recipient from the National Health Research Institutes in Taiwan. TGI operates an ISO/IEC 17025 accredited NGS laboratory in the Biomedical Science Park, utilizing hardware-accelerated supercomputing and collaborating with international AI gene interpretation companies. They also partner with medical centers and specialists to build an Asian disease gene database. TGI aims to become a leading provider of genetic testing services and disease big data solutions in the Asia-Pacific region, focusing on improving genetic and rare disease testing accessibility, affordability, and accuracy in precision medicine across areas like oncology and microbiology. Their core strengths include industry-academia collaboration with NHRI, an accredited laboratory, advanced computing, CE-IVD certified AI interpretation, hospital partnerships, and an Asian genetic database.
Taiwan Genome Industry Alliance
Taiwan Genome Industry Alliance Inc. (TGI) is a disease-focused company driven by genomics sequencing and data. They are the sole technology transfer and licensing recipient from the National Health Research Institutes in Taiwan. TGI operates an ISO/IEC 17025 accredited NGS laboratory in the Biomedical Science Park, utilizing hardware-accelerated supercomputing and collaborating with international AI gene interpretation companies. They also partner with medical centers and specialists to build an Asian disease gene database. TGI aims to become a leading provider of genetic testing services and disease big data solutions in the Asia-Pacific region, focusing on improving genetic and rare disease testing accessibility, affordability, and accuracy in precision medicine across areas like oncology and microbiology. Their core strengths include industry-academia collaboration with NHRI, an accredited laboratory, advanced computing, CE-IVD certified AI interpretation, hospital partnerships, and an Asian genetic database.